Stock Events

Stock Events

Abattis Bioceuticals 

$0
5
+$0+2,900% Monday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
2,481
Avg. Volume
0
Mkt Cap
14,334.12
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.1
-0.07
-0.03
-0
Expected EPS
N/A
Actual EPS
-0.0021

Financials

-848.81%Profit Margin
Unprofitable
2014
2015
2016
2017
2018
2019
538,494.6Revenue
-4.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATTBF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same space as Abattis.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, competing across multiple segments of the cannabis market.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with Abattis in the cannabis industry.
Organigram Global
OGI
Mkt Cap217.58M
OrganiGram Holdings is a producer and seller of medical and recreational cannabis, competing in the same market as Abattis.
Curaleaf
CURLF
Mkt Cap2.16B
Curaleaf Holdings, Inc. operates in the medical and recreational cannabis market, making it a competitor by offering similar cannabis-based products.

About

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Francesco Paolini
Country
CA
ISIN
CA00258G1037

Listings

OTC Link
US
ATTBF

0 Comments

Share your thoughts

FAQ

What is Abattis Bioceuticals stock price today?▼
The current price of ATTBF is $0 USD — it has increased by +2,900% in the past 24 hours. Watch Abattis Bioceuticals stock price performance more closely on the chart.
What is Abattis Bioceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abattis Bioceuticals stocks are traded under the ticker ATTBF.
Is Abattis Bioceuticals stock price growing?▼
ATTBF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Abattis Bioceuticals has showed a -70% decrease.
What is Abattis Bioceuticals market cap?▼
Today Abattis Bioceuticals has the market capitalization of 14,334.12
What were Abattis Bioceuticals earnings last quarter?▼
ATTBF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abattis Bioceuticals revenue for the last year?▼
Abattis Bioceuticals revenue for the last year amounts to 538,494.6 USD.
What is Abattis Bioceuticals net income for the last year?▼
ATTBF net income for the last year is -4.57M USD.
In which sector is Abattis Bioceuticals located?▼
Abattis Bioceuticals operates in the Health Care sector.
When did Abattis Bioceuticals complete a stock split?▼
The last stock split for Abattis Bioceuticals was on September 11, 2012 with a ratio of 1:5.
Where is Abattis Bioceuticals headquartered?▼
Abattis Bioceuticals is headquartered in Vancouver, CA.